Literature DB >> 19955384

ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.

Sonya B Dumanis1, Joseph A Tesoriero, Lenard W Babus, Madeline T Nguyen, Justin H Trotter, Mary Jo Ladu, Edwin J Weeber, R Scott Turner, Baoji Xu, G William Rebeck, Hyang-Sook Hoe.   

Abstract

The three human alleles of apolipoprotein E (APOE) differentially influence outcome after CNS injury and affect one's risk of developing Alzheimer's disease (AD). It remains unclear how ApoE isoforms contribute to various AD-related pathological changes (e.g., amyloid plaques and synaptic and neuron loss). Here, we systematically examined whether apoE isoforms (E2, E3, E4) exhibit differential effects on dendritic spine density and morphology in APOE targeted replacement (TR) mice, which lack AD pathological changes. Using Golgi staining, we found age-dependent effects of APOE4 on spine density in the cortex. The APOE4 TR mice had significantly reduced spine density at three independent time points (4 weeks, 3 months, and 1 year, 27.7% +/- 7.4%, 24.4% +/- 8.6%, and 55.6% +/- 10.5%, respectively) compared with APOE3 TR mice and APOE2 TR mice. Additionally, in APOE4 TR mice, shorter spines were evident compared with other APOE TR mice at 1 year. APOE2 TR mice exhibited longer spines as well as significantly increased apical dendritic arborization in the cortex compared with APOE4 and APOE3 TR mice at 4 weeks. However, there were no differences in spine density across APOE genotypes in hippocampus. These findings demonstrate that apoE isoforms differentially affect dendritic complexity and spine formation, suggesting a role for APOE genotypes not only in acute and chronic brain injuries including AD, but also in normal brain functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955384      PMCID: PMC2846754          DOI: 10.1523/JNEUROSCI.4026-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

Review 1.  Apolipoprotein E receptors: linking brain development and Alzheimer's disease.

Authors:  J Herz; U Beffert
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP.

Authors:  D T Pak; S Yang; S Rudolph-Correia; E Kim; M Sheng
Journal:  Neuron       Date:  2001-08-02       Impact factor: 17.173

3.  Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons.

Authors:  Jens Brodbeck; Maureen E Balestra; Ann M Saunders; Allen D Roses; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

4.  APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women.

Authors:  Antonio Daniele; Maria G Matera; Davide Seripa; Adele Acciarri; Alessandra Bizzarro; Alberto Pilotto; Carlo Masullo
Journal:  Arch Neurol       Date:  2009-07

5.  Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice.

Authors:  Alán Alpár; Uwe Ueberham; Martina K Brückner; Gudrun Seeger; Thomas Arendt; Ulrich Gärtner
Journal:  Brain Res       Date:  2006-06-15       Impact factor: 3.252

6.  Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.

Authors:  S Bellosta; B P Nathan; M Orth; L M Dong; R W Mahley; R E Pitas
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  Interaction of reelin with amyloid precursor protein promotes neurite outgrowth.

Authors:  Hyang-Sook Hoe; Kea Joo Lee; Rosalind S E Carney; Jiyeon Lee; Alexandra Markova; Ji-Yun Lee; Brian W Howell; Bradley T Hyman; Daniel T S Pak; Guojun Bu; G William Rebeck
Journal:  J Neurosci       Date:  2009-06-10       Impact factor: 6.167

8.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.

Authors:  B P Nathan; S Bellosta; D A Sanan; K H Weisgraber; R W Mahley; R E Pitas
Journal:  Science       Date:  1994-05-06       Impact factor: 47.728

9.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  109 in total

Review 1.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.

Authors:  Peter Penzes; Jon-Eric Vanleeuwen
Journal:  Brain Res Rev       Date:  2011-01-26

Review 2.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

3.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

4.  Systemic or Forebrain Neuron-Specific Deficiency of Geranylgeranyltransferase-1 Impairs Synaptic Plasticity and Reduces Dendritic Spine Density.

Authors:  David Hottman; Shaowu Cheng; Andrea Gram; Kyle LeBlanc; Li-Lian Yuan; Ling Li
Journal:  Neuroscience       Date:  2018-02-02       Impact factor: 3.590

5.  Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.

Authors:  L Chang; M Andres; J Sadino; C S Jiang; H Nakama; E Miller; T Ernst
Journal:  Neuroimage       Date:  2011-07-21       Impact factor: 6.556

Review 6.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

7.  Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.

Authors:  Abhik Sen; Daniel L Alkon; Thomas J Nelson
Journal:  J Biol Chem       Date:  2012-03-17       Impact factor: 5.157

8.  Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway.

Authors:  Espen Lien; Guro L Andersen; Yongde Bao; Heather Gordish-Dressman; Jon S Skranes; Torstein Vik; James A Blackman
Journal:  Dev Med Child Neurol       Date:  2013-02-05       Impact factor: 5.449

9.  The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants.

Authors:  Yiran Xu; Honglian Wang; Yanyan Sun; Qing Shang; Mingjie Chen; Tongchuan Li; Dengna Zhu; Lin He; Changlian Zhu; Qinghe Xing
Journal:  Mol Genet Genomics       Date:  2014-02-13       Impact factor: 3.291

Review 10.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.